๐ข Recruiting
Phase 3
๐ Investigational Drug / Biologic
NCT05183646
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
๐ University of Alabama at Birmingham โ Birmingham, Alabama
View Study & Checklist โ